- MS-DRGs are grouped by "Medical Service" to provide a meaningful way of summarizing utilization data.
- MS-DRGs are based on FY 2023 regulations.
MS-DRG | MS-DRG Description |
---|---|
014 | ALLOGENEIC BONE MARROW TRANSPLANT |
016 | AUTOLOGOUS BONE MARROW TRANSPLANT WITH CC/MCC |
017 | AUTOLOGOUS BONE MARROW TRANSPLANT WITHOUT CC/MCC |
018 | CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL AND OTHER IMMUNOTHERAPIES |
054 | NERVOUS SYSTEM NEOPLASMS WITH MCC |
055 | NERVOUS SYSTEM NEOPLASMS WITHOUT MCC |
146 | EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH MCC |
147 | EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITH CC |
148 | EAR, NOSE, MOUTH AND THROAT MALIGNANCY WITHOUT CC/MCC |
180 | RESPIRATORY NEOPLASMS WITH MCC |
181 | RESPIRATORY NEOPLASMS WITH CC |
182 | RESPIRATORY NEOPLASMS WITHOUT CC/MCC |
374 | DIGESTIVE MALIGNANCY WITH MCC |
375 | DIGESTIVE MALIGNANCY WITH CC |
376 | DIGESTIVE MALIGNANCY WITHOUT CC/MCC |
435 | MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MCC |
436 | MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH CC |
437 | MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITHOUT CC/MCC |
597 | MALIGNANT BREAST DISORDERS WITH MCC |
598 | MALIGNANT BREAST DISORDERS WITH CC |
599 | MALIGNANT BREAST DISORDERS WITHOUT CC/MCC |
686 | KIDNEY AND URINARY TRACT NEOPLASMS WITH MCC |
687 | KIDNEY AND URINARY TRACT NEOPLASMS WITH CC |
688 | KIDNEY AND URINARY TRACT NEOPLASMS WITHOUT CC/MCC |
722 | MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH MCC |
723 | MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH CC |
724 | MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC |
754 | MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH MCC |
755 | MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH CC |
756 | MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC |
834 | ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITH MCC |
835 | ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITH CC |
836 | ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITHOUT CC/MCC |
837 | CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC |
838 | CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT |
839 | CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC |
840 | LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MCC |
841 | LYMPHOMA AND NON-ACUTE LEUKEMIA WITH CC |
842 | LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT CC/MCC |
843 | OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MCC |
844 | OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH CC |
845 | OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT CC/MCC |
846 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC |
847 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC |
848 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC |
849 | RADIOTHERAPY |